Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-11-10
pubmed:abstractText
LINGO-1 is a CNS-specific protein and a functional component of the NgR1/p75/LINGO-1 and NgR1/TAJ(TROY)/LINGO-1 signaling complexes that mediate inhibition of axonal outgrowth. These receptor complexes mediate the axonal growth inhibitory effects of Nogo, myelin-associated glycoprotein (MAG) and oligodendrocyte-myelin glycoprotein (OMgp) via RhoA activation. Soluble LINGO-1 (LINGO-1-Fc), which acts as an antagonist of these pathways by blocking LINGO-1 binding to NgR1, was administered to rats after dorsal or lateral hemisection of the spinal cord. LINGO-1-Fc treatment significantly improved functional recovery, promoted axonal sprouting and decreased RhoA activation and increased oligodendrocyte and neuronal survival after either rubrospinal or corticospinal tract transection. These experiments demonstrate an important role for LINGO-1 in modulating axonal outgrowth in vivo and that treatment with LINGO-1-Fc can significantly enhance recovery after spinal cord injury.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1044-7431
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
311-20
pubmed:dateRevised
2011-6-29
pubmed:meshHeading
pubmed-meshheading:17011208-Analysis of Variance, pubmed-meshheading:17011208-Animals, pubmed-meshheading:17011208-Apoptosis, pubmed-meshheading:17011208-Axons, pubmed-meshheading:17011208-Caspase 3, pubmed-meshheading:17011208-Disease Models, Animal, pubmed-meshheading:17011208-Dose-Response Relationship, Drug, pubmed-meshheading:17011208-Forelimb, pubmed-meshheading:17011208-Humans, pubmed-meshheading:17011208-Immunohistochemistry, pubmed-meshheading:17011208-In Situ Nick-End Labeling, pubmed-meshheading:17011208-MAP Kinase Kinase 4, pubmed-meshheading:17011208-Membrane Proteins, pubmed-meshheading:17011208-Nerve Regeneration, pubmed-meshheading:17011208-Nerve Tissue Proteins, pubmed-meshheading:17011208-Organogenesis, pubmed-meshheading:17011208-Protein Binding, pubmed-meshheading:17011208-RNA-Binding Proteins, pubmed-meshheading:17011208-Rats, pubmed-meshheading:17011208-Rats, Sprague-Dawley, pubmed-meshheading:17011208-Recombinant Fusion Proteins, pubmed-meshheading:17011208-Recovery of Function, pubmed-meshheading:17011208-Spinal Cord Injuries, pubmed-meshheading:17011208-Time Factors, pubmed-meshheading:17011208-Tubulin, pubmed-meshheading:17011208-rhoA GTP-Binding Protein
pubmed:year
2006
pubmed:articleTitle
LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury.
pubmed:affiliation
Biogen Idec, Inc., 14 Cambridge Center, Cambridge, MA 02142, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't